We have shown that EVs conjugated with a peptide or a single domain antibody targeting EGFR promote the specific uptake of EVs by EGFR‐positive lung cancer cells, thereby enhancing the delivery of paclitaxel to lung tumours for better treatment of lung cancer.20 This evidence concerns the gene EGFR and lung carcinoma.